Owner Investor / Financier Operator Developer Technology licensor Technology / equipment supplier
AGC Group (AGC Inc.; formerly Asahi Glass Co., Ltd.) is a global manufacturer of glass, chemicals, and advanced materials founded in 1907 and headquartered in Tokyo, Japan. The company serves construction, automotive, electronics, and life-science markets, with manufacturing and R&D operations across Asia, Europe, and the Americas.
Within the chemical industry, AGC produces chlor-alkali products, fluorochemicals and fluoropolymers (such as PTFE and ETFE), fluoroelastomers, ion-exchange membranes, and specialty materials for semiconductor and electronic applications, alongside ceramics and other industrial materials. The group also participates in downstream derivatives in selected regions and provides biopharmaceutical contract development and manufacturing services through AGC Biologics.
Also known as Asahi Glass Co., Asahi Glass Co., Ltd., AGC Inc., and AGC.
chemXplore tracks 6 projects involving AGC, of which 3 are active.
Besides these 3, the record holds 3 completed projects.
Closest to start-up first.
The 3 that are completed, on hold or cancelled are in the record. See all 6 in chemXplore →
NEDO‑selected R&D (FY2026–FY2028) will integrate quantum computing and AI to accelerate materials discovery and validate simulations with experiments across batteries, optics, superconductors and colorants.
Process development and GMP manufacturing of lactoperoxidase and glucose oxidase to support an IND filing and a Phase II clinical trial in the US.
Speech-to-text plus generative AI structures shop-floor voice logs into reusable digital assets, cutting work-analysis time by over 90% and enabling tacit-knowledge transfer.
Yokohama technical center began cell therapy process development in July 2025 and has been awarded multiple exosome and T‑cell projects, including a program transferred from Milan.
Hybrid furnace to cut CO₂ from flat glass production; construction starts Jan 2027, production H2 2027; co-funded by the EU ETS Innovation Fund.
End-to-end CDMO support for NTX-083 completed — manufacturing process established and IND CMC documentation prepared ahead of planned US clinical trials in 2026.
Japan's first closed-loop scheme turns demolition window glass into cullet for clear float glass; 81 t used in flat glass, 149 t collected, estimated CO₂ cut 49 t.
Deal covers commercial manufacturing of multiple biopharmaceuticals using new Yokohama site; revenue expected at several tens of billions of yen; GMP services targeted for 2027.
The 6 sharing the most projects, of 10.
